HepMadness

Evidence Corner

Early survivorship after liver transplantation: a qualitative study identifying challenges in recovery from the patient and caregiver perspective

https://journals.lww.com/lt/Fulltext/2022/03000/Early_Survivorship_After_Liver_Transplantation__A.14.aspx

Daniyal Abbas

September 25, 2023

Evidence Corner

Increasing NAFLD–related mortality rates in the United States

https://journals.lww.com/hepcomm/fulltext/2023/07010/increasing_nonalco…

Tolga Gidener

September 25, 2023

Evidence Corner

mHealth program leads to significant weight loss in patients with NASH

https://journals.lww.com/hepcomm/Fulltext/2023/04010/Mobile_health_life…

Eytan Palte

September 25, 2023

Evidence Corner

Covert HE and Sleep Disturbances in Cirrhosis

https://pubmed.ncbi.nlm.nih.gov/36724117/#:~:text=Results%3A%20Across%2….

Jeff Gibbs

September 25, 2023

Evidence Corner

Increasing Rates of Alcohol-associated Liver Disease Mortality

https://journals.lww.com/hepcomm/fulltext/2023/07010/rising_alcohol_ass…

Sebastian Niezen

September 25, 2023

Evidence Corner

Sociodemographic Disparities in the Receipt of Treatment and Survival in Hepatocellular Carcinoma

https://journals.lww.com/hepcomm/Fulltext/2022/05000/Racial,_Ethnic,_an…

Simone Jarrett

September 25, 2023

Evidence Corner

Safety of Naltrexone Use in Patients with Liver Disease

https://journals.lww.com/hepcomm/fulltext/2022/12000/naltrexone_for_alc…

Jonathan Lin

September 25, 2023

Evidence Corner

AUD Medications Associated with Improved Survival in Patients with Alcohol-associated Cirrhosis

https://journals.lww.com/hepcomm/pages/articleviewer.aspx?year=2023&iss…

Brittany Bromfield

September 25, 2023

Evidence Corner

Social determinants of health impact mortality from HCC and cholangiocarcinoma: a population-based cohort study

https://journals.lww.com/hepcomm/pages/articleviewer.aspx?year=2023&iss…

Adal Guzman

September 25, 2023

HepMadness

Early survivorship after liver transplantation: a qualitative study identifying challenges in recovery from the patient and caregiver perspective

Increasing NAFLD–related mortality rates in the United States

mHealth program leads to significant weight loss in patients with NASH

Covert HE and Sleep Disturbances in Cirrhosis

Increasing Rates of Alcohol-associated Liver Disease Mortality

Sociodemographic Disparities in the Receipt of Treatment and Survival in Hepatocellular Carcinoma

Safety of Naltrexone Use in Patients with Liver Disease

AUD Medications Associated with Improved Survival in Patients with Alcohol-associated Cirrhosis

Social determinants of health impact mortality from HCC and cholangiocarcinoma: a population-based cohort study

Subscribe

Thanks for signing up!